|
【结 构 式】 
|
【药物名称】NPS-2390 【化学名称】N-(1-Adamantyl)quinoxaline-2-carboxamide 【CA登记号】226878-01-9 【 分 子 式 】C19H21N3O 【 分 子 量 】307.39872 |
【开发单位】NPS Pharmaceuticals (Originator) 【药理作用】Antiepileptic Drugs, Cerebrovascular Diseases, Treatment of, Ischemic Stroke, Treatment of, NEUROLOGIC DRUGS, Stroke, Treatment of, mglu1 Antagonists, mglu5 Antagonists |
合成路线1
The title amide has been obtained by condensation of adamantan-1-amine (I) with quinoxaline-2-carbonyl chloride (II) in pyridine.
| 【1】 Moe, S.T.; Smith, D.L.; Sheehan, S.M.; Shcherbakova, I.; Travato, R.; Walton, R.; Barmore, R.; Stormann, T.M.; DelMar, E.G.; VanWagenen, B.C. (NPS Pharmaceuticals, Inc.); Metabotropic glutamate receptor antagonists for treating central nervous system diseases. EP 1037878; JP 2001524468; WO 9926927 . |
Extended Information